This Review discusses the molecular processes and clonal evolution that lead to myelodysplastic syndrome (MDS) and secondary acute myeloid leukaemia, highlighting the ways in which these insights are shaping the clinical management of MDS.
- Adam S. Sperling
- Christopher J. Gibson
- Benjamin L. Ebert